Navigation Links
Wayne State University and Oakwood Partner in New Device to Combat Congestive Heart Failure
Date:4/7/2008

DEARBORN, Mich., April 7, 2008 /PRNewswire-USNewswire/ -- Wayne State University School of Medicine and Oakwood Healthcare System surgeons successfully implanted a new device designed to combat congestive heart failure in a 49-year-old patient. The device could become a leading tool in the arsenal to combat a condition that kills 300,000 Americans annually.

(Photo: http://www.newscom.com/cgi-bin/prnh/20080407/DC18745 )

The April 1 surgery took place at Oakwood Hospital & Medical Center in Dearborn. The patient, a Hamtramck man, was suffering from an advanced stage of congestive heart failure.

Surgeons said the patient is "doing well," and was expected to remain in the hospital between five and seven days. The average hospital stay for an open heart surgery patient is eight to 10 days.

The entire procedure took 1 hour and six minutes. Traditional open heart surgery takes hours.

Designated PEERLESS-HF (Prospective Evaluation of Elastic Restraint to LESSen the effects of Heart Failure), the HeartNet therapy researched collaboratively by the School of Medicine and Oakwood Healthcare System involves an implantable device that wraps around the heart to increase its pumping ability.

The HeartNet is an elasticized structure implanted via a minimally invasive procedure. Essentially, the device snugs around and conforms to the heart in a gentle hug, augmenting the function of the heart, and potentially preventing congestive heart failure from advancing by reversing the progressive enlargement of the failing heart. This process allows surgeons to make an incision less than an inch long, opposed to a traditional open heart surgery incision, which can be 12 inches.

Dilated cardiomyopathy, one major cause of congestive heart failure, is a condition in which the heart becomes weakened and enlarged, reducing its ability to pump effic
'/>"/>

SOURCE Oakwood Healthcare System; Wayne State University Schoolof Medicine
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
2. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
3. Use it or Lose it: A New Theory About Preserving Erectile Function After Prostate Surgery
4. Gene Fusion Subtypes in Prostate Carcinoma Have Clinical Implications
5. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
6. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
7. Peregrine Reports Data Showing Bavituximabs Potential to Shrink Prostate Tumors
8. Peregrine Researchers Report Data Showing Bavituximabs Potential to Shrink Human Prostate Tumors in Model of Relapsed Disease
9. Statement by KCP Chairman Dr. Edward Jones in Response to FDA Advisory Committee on Benefits and Risks of Erythropoietin-Stimulating Agents in Treatment of Kidney Patients
10. K-State Researchers Bringing Expertise to Kansas City Symposium on Disease and National Security
11. Vaccine Study in New England Journal of Medicine Wrong in Concluding Mercury Exposures are Harmless, States SafeMinds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2008)... Md., Dec. 1 Vanda Pharm...ion in The Lancet , one of the world,s leading me...novel circadian regulator, experimental compound t...am et al(1) is entitled "Melatonin agonist tasimel...time shift: two randomised controlled multicentre ...
(Date:12/1/2008)...IS, Dec. 1 Roche announced today t...ferences in perceived pain and,discomfort associa...ood,glucose monitoring systems and lancing device...cated that, overall, the ACCU-CHEK Aviva and ACCU-...s and the ACCU-CHEK Multiclix, ACCU-CHEK,Softclix...
(Date:12/1/2008)...inence is still the best policy , , ROCHES...w study from Mayo Clinic finds the use of the drug...lic hepatitis, an acute inflammation of the liver ...sults of the study are published in the December i...nal.org/ ). , , VIDEO ALERT: Additional au...
(Date:12/1/2008)...nce Call Scheduled for Tuesday, December 9 at 11:0... , , SOUTH SAN FRANCISCO, Calif., Dec. 1 ..., Inc. (Nasdaq: SNSS ), a biopharmaceutical comp...on of new oncology therapeutics, today announced n...loid leukemia (AML) will be presented during the 5...
Breaking Medicine Technology:Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals' Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet 2Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals' Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet 3Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals' Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet 4Study Shows ACCU-CHEK(R) Blood Glucose Monitoring Systems and Lancing Devices Are Least Painful 2Study Shows ACCU-CHEK(R) Blood Glucose Monitoring Systems and Lancing Devices Are Least Painful 3Mayo Clinic Seeks New Therapies for Alcoholic Hepatitis 2Mayo Clinic Seeks New Therapies for Alcoholic Hepatitis 3Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia To Be Presented at ASH 2Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia To Be Presented at ASH 3A bees future as queen or worker may rest with parasitic fly 4223 1A bees future as queen or worker may rest with parasitic fly 4223 2Nu Skin Enterprises and Toyo Bio Pharma Enter Agreement for Joint Product Research and Development 24435 1Nu Skin Enterprises and Toyo Bio Pharma Enter Agreement for Joint Product Research and Development 24435 2Healthcare Executives Well Rewarded for Their Work 24431 1Healthcare Executives Well Rewarded for Their Work 24431 2Hypnosis shown to reduce symptoms of dementia 24427 1
...cokinetics and Dose Proportionality of,Company,s O...tics,Journal -, LAVAL, QC, June 29, 2007 /PRNewswi...t it will present a poster discussing the dose,tit...t the 3rd,International Forum on Pain Medicine to ...a. , The poster compares two different titration s...
...2007: Chi-Med, the Hutchison Whampoa backed pharma...itive results for its Phase II,proof-of-concept st...litis, a form of inflammatory bowel disease. The ...tolerated and showed an,equivalent drop in clinica..., the current first-line standard of care in,mild-...
Other Medicine Technology:Labopharm to Present Poster on Dose Titration of Once-daily,Tramadol at 3rd International Forum on Pain Medicine 2Labopharm to Present Poster on Dose Titration of Once-daily,Tramadol at 3rd International Forum on Pain Medicine 3Chi-Med Announces Positive Phase II Proof-of-Concept Data for,HMPL-004 in Ulcerative Colitis 2Chi-Med Announces Positive Phase II Proof-of-Concept Data for,HMPL-004 in Ulcerative Colitis 3Chi-Med Announces Positive Phase II Proof-of-Concept Data for,HMPL-004 in Ulcerative Colitis 4Chi-Med Announces Positive Phase II Proof-of-Concept Data for,HMPL-004 in Ulcerative Colitis 5Chi-Med Announces Positive Phase II Proof-of-Concept Data for,HMPL-004 in Ulcerative Colitis 6Chi-Med Announces Positive Phase II Proof-of-Concept Data for,HMPL-004 in Ulcerative Colitis 7Chi-Med Announces Positive Phase II Proof-of-Concept Data for,HMPL-004 in Ulcerative Colitis 8
(Date:12/2/2008)...es that the SouthEast Alaska Regional Health Conso... Rhapsody™ Integration Engine to help the di...acy, laboratory and business programs communicate ...ity to statewide systems such as VacTrAK (the Stat...MIS and clinical documentation tool used by substa...
(Date:12/2/2008)...Population Services International (PSI) is launchi...ally reduce the number of African children dying e...ree artemisinin-based combination therapies (ACT) ...ildren suspected of having malaria. This quick-res...etermine if it reduces the number of African child...
(Date:12/1/2008)...Toy Puppies to the Obama Daughters , , WASH... been made of President-Elect Obama,s first promis...ughter,s asthma and allergies, and timing issues, .... So, in the meantime, the Asthma and Allergy Fou...mp; allergy friendly" toy puppies to the Obama chi...
(Date:12/1/2008)...tomography (CT) colonography, also known as virtua... diseases at oncecolorectal cancer and osteoporosi...0. Results of the study will be presented today at... North America (RSNA). , "With CT colonography, ... were able to identify patients with osteoporosis,...
Breaking Medicine News(10 mins):Health News:SouthEast Alaska Regional Health Consortium Selects Orion Health's Rhapsody Integration Engine for Full-scale Application Integration and Monitoring 2Health News:SouthEast Alaska Regional Health Consortium Selects Orion Health's Rhapsody Integration Engine for Full-scale Application Integration and Monitoring 3Health News:Canada Supports Ground-Breaking Malaria Treatment Program in Sub-Saharan Africa 2Health News:Canada Supports Ground-Breaking Malaria Treatment Program in Sub-Saharan Africa 3Health News:Asthma and Allergy Foundation Helps New First-Dad Keep His First Promise 2Health News:CT colonography offers 1-stop screening for cancer and osteoporosis 2
...ain medications widely prescribed for rotator cuff...or cuff is composed of the muscles and tendons tha...it to the shoulder joint. The research involved 18...repair surgery. One-third of the rats were treated...
...antiretroviral therapy HAART, the cytomegalovirus ...ortunistic// infections that spread out of control...shorter time to death. Researchers assessed CMV s...HIV using a standard test. Investigators followed ...
...reened for cervical cancer, according to a new stu...routine // Pap smears are unnecessary for women wh...ancerous diseases. Since most of these women no lo...r cervical cancer. A survey done by researchers on...
...ption may be partly to blame for patients sufferin...ainly caused // by alcohol abuse and gall stones. ...nal pain, often accompanied by nausea and vomiting.... Researchers say pancreatitis has a poor prognosi...
Other Medicine News:
...The new Finnpipette Focus from Thermo Labsystems w...h uncompromising performance. Advanced features s...lume adjustment on microvolumes help to define thi...new interchangeable handle plate offers a custom f...
Enhanced drug and formulary reference with integrated ID treatment guide and tools. Increase patient safety and satisfaction with our premium drug reference.
Designed to inform decision making, PatientKeeper's Clinical Results delivers complete patient data on demand. Clinicians can rely on immediate access to lab results, medication profiles, microbiolog
The SJM Tailor annuloplasty ring, a fully flexible ring, is constructed of a barium-impregnated silicone strip covered with a knitted polyester sewing cuff.
Medicine Products: